111 related articles for article (PubMed ID: 12413866)
1. 1-Methoxy-, 1-deoxy-11-hydroxy- and 11-hydroxy-1-methoxy-Delta(8)-tetrahydrocannabinols: new selective ligands for the CB2 receptor.
Huffman JW; Bushell SM; Miller JR; Wiley JL; Martin BR
Bioorg Med Chem; 2002 Dec; 10(12):4119-29. PubMed ID: 12413866
[TBL] [Abstract][Full Text] [Related]
2. 1-Bromo-3-(1',1'-dimethylalkyl)-1-deoxy-Δ(8)-tetrahydrocannabinols: New selective ligands for the cannabinoid CB(2) receptor.
Huffman JW; Hepburn SA; Lyutenko N; Thompson AL; Wiley JL; Selley DE; Martin BR
Bioorg Med Chem; 2010 Nov; 18(22):7809-15. PubMed ID: 20943404
[TBL] [Abstract][Full Text] [Related]
3. 3-(1',1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor.
Huffman JW; Liddle J; Yu S; Aung MM; Abood ME; Wiley JL; Martin BR
Bioorg Med Chem; 1999 Dec; 7(12):2905-14. PubMed ID: 10658595
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships for 1',1'-dimethylalkyl-Delta8-tetrahydrocannabinols.
Huffman JW; Miller JR; Liddle J; Yu S; Thomas BF; Wiley JL; Martin BR
Bioorg Med Chem; 2003 Apr; 11(7):1397-410. PubMed ID: 12628666
[TBL] [Abstract][Full Text] [Related]
5. Enantioselective synthesis of 1-methoxy- and 1-deoxy-2'-methyl-delta8-tetrahydrocannabinols: new selective ligands for the CB2 receptor.
Huffman JW; Bushell SM; Joshi SN; Wiley JL; Martin BR
Bioorg Med Chem; 2006 Jan; 14(1):247-62. PubMed ID: 16165365
[TBL] [Abstract][Full Text] [Related]
6. CB2 receptor ligands.
Huffman JW
Mini Rev Med Chem; 2005 Jul; 5(7):641-9. PubMed ID: 16026310
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and pharmacology of 11-nor-1-methoxy-9-hydroxyhexahydrocannabinols and 11-nor-1-deoxy-9-hydroxyhexahydrocannabinols: new selective ligands for the cannabinoid CB2 receptor.
Marriott KS; Huffman JW; Wiley JL; Martin BR
Bioorg Med Chem; 2006 Apr; 14(7):2386-97. PubMed ID: 16321538
[TBL] [Abstract][Full Text] [Related]
8. Novel cannabinol probes for CB1 and CB2 cannabinoid receptors.
Mahadevan A; Siegel C; Martin BR; Abood ME; Beletskaya I; Razdan RK
J Med Chem; 2000 Oct; 43(20):3778-85. PubMed ID: 11020293
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the development of selective ligands for the cannabinoid CB(2) receptor.
Marriott KS; Huffman JW
Curr Top Med Chem; 2008; 8(3):187-204. PubMed ID: 18289088
[TBL] [Abstract][Full Text] [Related]
10. Bornyl- and isobornyl-Delta8-tetrahydrocannabinols: a novel class of cannabinergic ligands.
Lu D; Guo J; Duclos RI; Bowman AL; Makriyannis A
J Med Chem; 2008 Oct; 51(20):6393-9. PubMed ID: 18826296
[TBL] [Abstract][Full Text] [Related]
11. The search for selective ligands for the CB2 receptor.
Huffman JW
Curr Pharm Des; 2000 Sep; 6(13):1323-37. PubMed ID: 10903395
[TBL] [Abstract][Full Text] [Related]
12. Importance of the C-1 substituent in classical cannabinoids to CB2 receptor selectivity: synthesis and characterization of a series of O,2-propano-delta 8-tetrahydrocannabinol analogs.
Reggio PH; Wang T; Brown AE; Fleming DN; Seltzman HH; Griffin G; Pertwee RG; Compton DR; Abood ME; Martin BR
J Med Chem; 1997 Sep; 40(20):3312-8. PubMed ID: 9379452
[TBL] [Abstract][Full Text] [Related]
13. Novel 1',1'-chain substituted Delta(8)-tetrahydrocannabinols.
Papahatjis DP; Nikas SP; Andreou T; Makriyannis A
Bioorg Med Chem Lett; 2002 Dec; 12(24):3583-6. PubMed ID: 12443781
[TBL] [Abstract][Full Text] [Related]
14. (-)-11-Hydroxy-7'-isothiocyanato-1',1'-dimethylheptyl-delta 8-THC: a novel, high-affinity irreversible probe for the cannabinoid receptor in the brain.
Guo Y; Abadji V; Morse KL; Fournier DJ; Li X; Makriyannis A
J Med Chem; 1994 Nov; 37(23):3867-70. PubMed ID: 7966145
[No Abstract] [Full Text] [Related]
15. A novel electrophilic high affinity irreversible probe for the cannabinoid receptor.
Morse KL; Fournier DJ; Li X; Grzybowska J; Makriyannis A
Life Sci; 1995; 56(23-24):1957-62. PubMed ID: 7776819
[TBL] [Abstract][Full Text] [Related]
16. A 3D-QSAR study on the structural requirements for binding to CB(1) and CB(2) cannabinoid receptors.
Fichera M; Cruciani G; Bianchi A; Musumarra G
J Med Chem; 2000 Jun; 43(12):2300-9. PubMed ID: 10882356
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor.
Buckley NE; McCoy KL; Mezey E; Bonner T; Zimmer A; Felder CC; Glass M; Zimmer A
Eur J Pharmacol; 2000 May; 396(2-3):141-9. PubMed ID: 10822068
[TBL] [Abstract][Full Text] [Related]
18. Paradoxical pharmacological effects of deoxy-tetrahydrocannabinol analogs lacking high CB1 receptor affinity.
Wiley JL; Jefferson RG; Griffin G; Liddle J; Yu S; Huffman JW; Martin BR
Pharmacology; 2002 Oct; 66(2):89-99. PubMed ID: 12207116
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and pharmacology of the isomeric methylheptyl-delta8-tetrahydrocannabinols.
Huffman JW; Liddle J; Duncan SG; Yu S; Martin BR; Wiley JL
Bioorg Med Chem; 1998 Dec; 6(12):2383-96. PubMed ID: 9925296
[TBL] [Abstract][Full Text] [Related]
20. Separation of cannabinoid receptor affinity and efficacy in delta-8-tetrahydrocannabinol side-chain analogues.
Griffin G; Williams S; Aung MM; Razdan RK; Martin BR; Abood ME
Br J Pharmacol; 2001 Jan; 132(2):525-35. PubMed ID: 11159703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
